News Releases

NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Pivot Bio, one of the world's most innovative agtech companies, will take center stage during Climate Week in New York City (Sept. 22–24). CEO Chris Abbott will join global business and sustainability leaders to highlight how agriculture is advancing climate solutions, reducing costs and strengthening the economic resilience of rural communities.

On Monday, Sept. 22, he will participate in ringing the Nasdaq Opening Bell, underscoring the growing role of sustainable innovation in capital markets. Later in the week, he will join a high-profile panel, The Future of Planetary Health: Investing for Impact, moderated by Jason Knauf, CEO of The Earthshot Prize and panelists including Anders Spohr, Managing Partner & Head of Planetary Health Investments, Novo Holdings; Laura Turner Seydel, Director, Turner Foundation; and Wawira Njiru, Founder, Food4Education.

During Climate Week, Abbott will also participate in additional panel discussions and investor dialogues, underscoring Pivot Bio's leadership at the intersection of business, agriculture, and climate.

Recognized by Fast Company as one of the World's Most Innovative Companies and by TIME for three consecutive years as one of the Best Inventions, Pivot Bio's industry-leading microbial nitrogen-fixing technologies are among the most talked about ag innovations in decades. From moonshot to commercial success, the company's products have made a difference across the United States, and soon in Brazil. The company has also done some notable work with smallholder farms in Kenya. Pivot Bio's products provide a weatherproof source of nitrogen directly to plant roots, helping farmers reduce costs, improve yields and strengthen long-term resilience in the face of volatile weather and rising input prices.

Key Results:

• Pivot Bio's innovative technology platform is:
• 99.5% less capital investment required to construct than conventional fertilizer facilities
• 1/20,000th the shipping volume of traditional nitrogen
• Reducing dependence on volatile global markets
• Eliminating working capital, price spikes and global supply chain constraints that plague growers and partners.
• Science-Backed Innovation
• PROVEN 40 is the most tested microbe on the market, backed by more than a decade of R&D, validation of outcomes on nearly 15 million acres, across 6,147 fields in 34 states, independent studies by 20+ leading universities, and its 200+ patent portfolio protecting American innovation.
• Market Expansion
• The company expanded beyond corn and small grains with CERT-N™, the first gene-edited nitrogen-fixing product for cotton. It replaces 20% of synthetic nitrogen while increasing lint yield by 50 pounds per acre – resulting in a 200% ROI in its first year.
• Measurable Impact Since 2022
• Since 2022, growers using Pivot Bio products have achieved remarkable results equivalent to avoiding emissions from 3.4 gas-fired power plants for one year, 7,200 rail cars of coal, or 270,000 homes' annual electricity use. Farmers have used more than 129,000 metric tons less synthetic nitrogen fertilizer, conserved more than 665 million gallons of manufacturing water, and avoided more than 102,600 metric tons of nitrate leaching.

About Pivot Bio

Pivot Bio, one of the world's leading innovative agtech companies, delivers to farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility.

Currently available in North America and soon in Brazil, the company's products are a breakthrough innovation and one of the agriculture industry's most promising climate solutions. Pivot Bio has been recognized three times by TIME magazine on its annual list of best inventions, by Fast Company on its World Changing Ideas and World's 50 Most Innovative Companies lists, by CNBC on its Disruptor 50 list of private companies, by Fortune on its Impact 20 list of startups driving social good and by MIT Tech Review as one of 15 climate tech companies to watch.

SOURCE Pivot Bio, Inc